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ABSTRACT
Objectives: Pre-operative anxiety control without increased post-operative psychomotor dysfunction is an anesthesia concern especially in 
ambulatory surgery; so, the development of a strong anxiolytic with minimal psychomotor impairment for premedication is desirable. In this study, it 
was hypothesized that Passiflora incarnata decreases pre-operative anxiety (PAN) similar to oxazepam.
Methods: In this double-blinded placebo controlled study, 128 patients were randomized into Passiflora group (n=68) who received oral P. incarnata 
and oxazepam group (n=60) who received oxazepam (10 mg) as premedication, 90 minutes before surgery. A numerical rating scale (NRS) was used 
for each patient to assess anxiety before, and 90 minutes following premedication. Psychomotor function was assessed with the trigger dot test (TDT) 
and the digit-symbol substitution test at arrival in the operating room, and 90 minutes after tracheal extubation.
Results: The 90th minutes NRS anxiety scores were significantly lower in the Passiflora group compared with oxazepam group (p<0.001). There were 
no significant differences in psychological variables, in groups, in the postanesthesia care unit.
Conclusion: In outpatient surgery, administration of oral P. incarnata as a premedication reduces PAN with similar psychomotor function impairment 
compared with pre-operative oral oxazepam.
Keywords: Anesthesia, Anxiety, Passiflora incarnata, Oxazepam, Psychomotor performance.
INTRODUCTION
The prevalence of pre-operative anxiety (PAN) has been reported 
to be up to 80% among adult patients [1,2]. PAN may be associated 
either with abnormal intraoperative hemodynamic profiles or an 
altered pharmacokinetics of anesthetic drugs, which may increase 
intraoperative anesthetic requirements [3].
PAN results in sympathetic neural activation and leads to increased 
heart rate, blood pressure, cardiac irritability [4], increased plasma 
epinephrine levels, and impaired balance of serum electrolytes [5]. 
There is also an association between high levels of pre-operative levels 
of anxiety and post-operative pain [6].
A variety of methods has been proposed for perioperative anxiety 
reduction. Pre-operative visit by the anesthesiologist can be a good 
way to reduce PAN [7,8]; medical interventions were considered in 
several studies, and benzodiazepines (BZD) was administered as the 
most commonly used PAN killer [9-11]. Meantime, scientists accept 
some herbal treatments nowadays and many people in different 
socioeconomic levels, are exploring herbal and other natural remedies 
for the treatment of their psychological conditions. The previous 
studies have reported the good effects of extracts of Passionflower or 
kava and combinations of L-lysine and L-arginine as a treatment for 
anxiety disorders [12].
In general, Passiflora incarnate may be regarded as a well characterized 
plant-derived agent with anxiolytic properties without negative 
sedative and cognition-attenuating side effects.
BZD are widely used by ambulatory surgery centers as painkillers; 
however, there are some concerns about prolongation of the recovery 
time.
To our knowledge, the use of Passiflora incarnata compared with 
a BZD in anesthesia has never been evaluated. In this study, it was 
hypothesized that oral P. incarnata would be an effective anxiolytic 
similar to oxazepam with limited impact on psychomotor function. The 
numerical rating scale (NRS) for anxiety 90 minutes after premedication 
was considered as the primary outcome of this study, and trigger dot 
test (TDT) and digit-symbol substitution test (DSST) were considered 
as secondary outcomes.
METHODS
The Institutional Ethics Review Board approved the study protocol, 
and an informed written consent was obtained from all the patients. 
Patients classified as the American Society of Anesthesiologists (ASA) 
physical Status I or II, aged 18-60, whom were candidates for outpatient 
inguinal herniorhaphy, were enrolled in this double-blind, randomized 
and parallel group trial. The patients with a history of anxiety disorders 
and consuming sedatives, analgesics, antidepressants, or antiepileptic 
drugs, addict patients and patients with any contraindications to the 
study drugs and patients with NRS for anxiety <1 and anyone who 
received any other drugs except study protocol drugs perioperatively, 
were not enrolled in the study. An anesthesiology technician who was 
not involved in anesthesia administration or inpatient observation 
prepared all drugs; so, both the anesthesiologist and the patients 
were blinded to group assignment. At the pre-operative visit, a trained 
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anesthesiology resident explained the study plan and three scales were 
used in the study for all the included patients. Based on computerized 
program patients were randomly divided into oxazepam (group O, 
n=60) or Passiflora (group P, n=68) group.
Approximately, 2 hrs before surgery, all patients were transferred 
to an isolated quiet room. All patients were monitored with an 
electrocardiogram, noninvasive blood pressure, and pulse oximetry. 
The patients in group O received premedication of oxazepam 10 mg, 
and those in group P received premedication of P. incarnata (500 mg, 
PassipyTM IranDarouk) orally 120 minutes before surgery.
An NRS scale was used to evaluate anxiety, where 0=No anxiety and 
10=The worst possible anxiety. The NRS scores were measured at 
baseline and 90 minutes after administration of premedication. The 
psychomotor function was assessed with the TDT and the DSST, at 
arrival in the operating room, and 90 minutes after tracheal extubation. 
The TDT is a variation of Bender-Gestalt test in which the patient is 
asked to connect a series of dots arranged in a specific pattern [13]. 
Points are subtracted for missing how many of dots. The DSST is a 
subtest of Wechsler Adult Intelligence Scale. It is a timed pen-and-paper 
test in which patients are required to appropriately match numbers and 
symbols. The score is the number of symbols correctly matched during 
90 seconds.
In the operating room, an infusion of 7 mL/kg/hrs isotonic saline 
(N/S) was administered. Anesthesia was induced with fentanyl 
2 µg/kg, propofol 2.5 mg/kg, and the tracheal intubation was 
facilitated by administration of cisatracurium 0.2 mg/kg. Anesthesia 
was maintained with propofol (100 µg/kg/minutes). Ventilation was 
adjusted to maintain normocapnia (end-tidal carbon dioxide partial 
pressure 4.7-5.3 kPa). The patients were actively warmed to keep 
normothermic based on core temperature (esophageal).
When skin suturing was started, anesthetic drug infusion was stopped 
and neuromuscular blockade was antagonized by intravenous 
administration of 0.04 mg/kg of neostigmine and 0.02 mg/kg atropine. 
They were considered awake and were tracheally extubated when they 
opened their eyes on command or after gentle tactile stimulation. In the 
postanesthesia care unit (PACU), patients received continuous oxygen 
via a nasal cannula (4 L/minutes). Post-operative pain was treated with 
3 mg/kg tramadol that was infused over 10 minutes. Post-operative 
nausea and vomiting was treated with 4 mg intravenous ondansetron. 
PACU discharge criteria included being awake and oriented, able to 
breathe deeply and cough freely, arterial blood pressure within 20% of 
pre-operative values, temperature >36°, absence of shivering, minimal 
pain, and minimal tolerable nausea. The time interval between arrival 
to PACU to discharge home (discharge time) was recorded for every 
patient. Patients were discharged from hospital when they met the 
minimum requirements based on the hospital discharge criteria.
Statistical analysis was performed using SPSS package (SPSS, Chicago, 
Illinois, USA), version 20. The distribution of age, weight, surgery 
duration, psychological variables, and NRS anxiety score was checked 
by the Kolmogorov–Smirnov test. They followed a normal distribution. 
Age, weight, surgery time, home discharge, the basal psychological 
variables, and the basal NRS anxiety score were compared in two groups 
by independent sample t-test. The paired t-test was used to assess the 
differences of NRS for anxiety, over the time in each group. The sedation 
scores were an ordinal scale measurement. To compare the sedation 
scores in groups in each measurement times, χ2 and Fisher’s exact tests 
(when appropriate) were used. To compare the sedation scores within 
groups against time, the Friedman test was used. The sex and ASA 
physical status class were compared with χ2-test. Statistical significance 
was noted for p<0.05. Data are expressed as mean±standard deviation 
(SD) and 95% confidence interval (95% confidence interval [CI]). We 
determined that a sample size of 60 in each group would be sufficient 
to detect a difference of three scores in the mean of anxiety score, 
estimating a SD of 3, a power of 95%, and a significance level of 5%; this 
number was increased to 65 per group, to allow for a predicted drop-
out from treatment of around 10%.
RESULTS
A total of 128 patients were enrolled in the study; there were no study 
protocol violations and all the data were analyzed. The study consisted 
of 68 patients in P group and 60 patients in O group. Age range of 
subjects was 18-59 years. Demographic data, duration of surgery, and 
ASA physical status were similar in between the two groups (Table 1).
Baseline NRS anxiety score was similar P (7.6±0.9) and O groups 
(6.6±1.0). There was a significant difference in 90th minutes NRS 
anxiety score of group P (4.4±1.2) and the group O (6.1±1.3) (p<0.001, 
CI: −2.0 to −1.1).
There were no significant differences between the two groups, in the 
measured psychomotor function scores, in the PACU. Recovery of 
psychomotor function scores was comparable in both groups, and the 
psychomotor function scores reached baseline values 90 minutes after 
extubation in both groups (Table 2).
Discharge time was similar between the two groups (Table 1).
DISCUSSION
This study demonstrated that patients who received oral Passiflora 
tablets, as premedication experienced less PAN that those who received 
pre-operative oxazepam, while the effect of both drugs on post-
operative psychomotor function was the same. Therefore, Passiflora 
is a safe and stronger candidate for PAN reduction in comparison to 
oxazepam. The recovery time was alike in both groups.
Movafegh et al. [8] conducted a study on the effects of the oral 
P. incarnata on PAN and reported good anxiolytic effects with limited 
effects on anesthesia drugs and recovery time compared to placebo. In 
this study, a similar study design was used to compare pre-operative 
anxiolysis effects of P. incarnata and oxazepam.







Age (year) 37.2±8.6 36.3±7.2 0.52
Sex (male/female) 38/30 36/24 0.63








SD: Standard deviation, ASA: American Society of Anesthesiologists








Passiflora group 0.9±0.2 1.2±0.4 0.79
Oxazepam group 0.8±0.2 1.1±0.3 0.56
TDTnr
Passiflora group 0.8±0.8 1.0±0.9 0.66
Oxazepam group 0.9±0.7 1.2±1.0 0.47
DSST
Passiflora group 31.1±5.1 28.6±5.0 0.75
Oxazepam group 30.8±5.0 29.1±4.8 0.54
TDTmm: Trieger dot test millimeter missed, TDTnr: Trieger dot test number 
missed, DSST: Digital-symbol substitution test, PACU: Postanesthesia care unit
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The genus Passiflora consist of about 500 species, it is the largest 
family among the Passifloraceae (Passion Flower family). Species 
of these apices grow in areas with warm temperatures and tropical 
weather and are distributed in North and South America. Extracts of 
Passiflora species are scarce in Asia, Africa, Australia and the tropics. 
Its indication for sleep disorders, restlessness, nervous stress, and 
anxiety has confirmed by various authentic institutions: British herbal 
compendium (Passion Flower Herb, England) [14], German commission 
standard licenses (Passiflora incarnate, Germany) [15].
P. incarnata as a species of these large genuses was studied as PAN killer 
herbs, in a few studies [16,17].
The mechanism of action is still unclear and several studies were 
done to discuss about that. The effects of P. incarnata coming 
extracts, petroleum ether, chloroform, methanol and water have been 
investigated about anxiolytic properties, in mice. Methanol extract 
from the leaves, stems, flowers, and whole plants had anxiolytic effect. 
Furthermore, Dhawan et al. observed that the roots and flowers of 
Passiflora incarnate neutralize, anxiolytic effects of other parts of the 
plant naturally and cause to increasing the effective dose, therefore, 
should be separate during processing [6].
In a study sought to isolate and identify the bioactive component 
of P. incarnata by chromatographic procedures, a fraction, which 
is obtained from the methanol extract of P. incarnata, showed a 
significant anxiolytic activity with a dose of 10 mg/kg in mice. This 
fraction consisted of two main components that were seen turquoise 
and blue while colored by fluorescent at wavelength of 366 nm of 
ultraviolet light maybe the bioactive component of P. incarnata is 
benzoflavone nucleus [17]. It is being recognized that dysfunction of the 
γ-aminobutyric acid (GABA) system is implicated in anxiety. Appel et al. 
investigated the in vitro effects of P. incarnata on GABA system of rats. 
The [3H]-GABA uptake into cortical synaptosomes of rat was inhibited 
by Passiflora, but Passiflora had no effect on GABA release and GABA 
transaminase activity. The ethanol-and the benzodiazepine-sites of the 
GABA A-receptor were not affected by Passiflora, and finally, this study 
classified the Passiflora, as an antagonist of the GABA B-receptor [18].
BZD is routinely used as a premedication to decrease PAN [10,19]. 
Two drugs from BZD group, chlordiazepoxide and diazepam as a single 
pretreatment dose, were studied on women’s PAN. The findings of this 
study were compared with those who received the previous consumed 
agents, such as opioids and phenothiazine products. The ability of 
these two drugs is documented to reduce PAN and chlordiazepoxide 
showed very mild sedative effects also [9]. Diazepam was used along 
with belladonna, before surgery in 40 neurosurgery patients. Two 
other pretreatment, belladonna without sedative drug, and belladonna 
with hydroxyzine were used in 78 similar patients. Sedative effect 
of diazepam was stronger than hydroxyzine and has not autonomic 
unwanted effects and seemed to be as safe as a simple drug such as 
belladonna [20]. However, diazepam has unwanted central sedative and 
muscle relaxant effects also.
Anxiolytic, and amnesic properties of low dose of BZD have been used 
in outpatient surgeries. Oral diazepam, 60-90 minutes before surgery 
reduces the level of stress hormones in the days after the surgery. 
Most commonly used BZD is diazepam, however, midazolam can be the 
better choice due to a shorter lifespan, lack of specific adverse events, 
and better recovery profile after ambulatory surgery.
In our center, oxazepam has been used routinely as a PAN killer, so 
it was chosen to compare it with Passiflora incarnate. Previously, 
Passiflora incarnate was used for the treatment of generalized anxiety 
disorders (GAD). In a randomized controlled study, 32 patients with 
GAD divided into Passiflora group recieving 45 drops of tincture of 
Passiflora and Oxazepam group which received 30 mg oxazepam, daily. 
4 days following treatment, the difference in groups was observed in 
the level of anxiety. Adverse reactions reported in patients treated 
with the Passiflora was lesser than oxazepam and therefore, ultimately, 
the authors concluded that the P. incarnata is an affective antianxiety 
agent and has fewer side effects comparing the synthetic antianxiety 
agents [21].
Akhondzadeh et al. [22] compared Passionflower (P. incarnata) with 
oxazepam in the treatment of GAD and reported Passiflora extract as an 
effective drug for curing GAD, and also this study confirmed the lower 
incidence of impairment, in job performance with Passiflora extract 
compared with oxazepam.
Extracts from Passiflora possess potential antidepressant effects which 
could be of therapeutic interest for using in the treatment of patients 
with depressive disorders [23]. It is very interesting that it has been 
proposed that the co-administration of Passiflora and BZD such as 
diazepam prevents the development of diazepam-dependence and the 
subsequent appearance of withdrawal effects [24].
The therapeutic dose of P. incarnata is 500-1000 mg three times 
daily [25]. However, the lowest approved treatment dosage of Passiflora 
for the PAN relief was 500 mg, 2 hrs before surgery, which were studied 
in Movafegh et al. study [8]. Furthermore, the minimum dose of 
Passiflora was used, in this study, which was reported safe in previous 
researches on adults [25].
Reducing levels of PAN will lead to decreased PAN and lesser post-
operative analgesic requirements, in pediatrics also [26] and it is 
valuable to evaluate the beneficial effects of P. incarnata and its 
minimum effective dose in pediatric patients with ambulatory surgery.
CONCLUSION
In conclusion, pre-operative administrations of oral Passiflora incarnate 
in outpatient patients decreases PAN more than oxazepam without 
recovery prolongation of psychomotor function impairment.
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